Skip to main content
Clinical Trials/NCT04676347
NCT04676347RecruitingNot Applicable

Evaluation and Improvement of the Health-care Quality in Semi-intensive Care Units

Mario Negri Institute for Pharmacological Research34 sites in 1 country39,000 target enrollmentStarted: July 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
39,000
Locations
34
Primary Endpoint
Outcome for stationary patients with high risk of variability

Study Overview

Brief Summary

The main aim of this study is to realize a system of continuous evaluation of healthcare quality in semi-intensive care units.

Detailed Description

Collecting data of semi-intensive care units' patients and structural data of hospitals, healthcare quality's indicators will be realized. Starting from those indicators of insuccess, specific for different kinds of patients, it will be possibile to evaluate the general level of care in each singular semi-intensive care unit. The study will least for 5 years, but at the end of every year it will be realized a report of analysis to see the results of each unit.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • all patients hospitalised in a semi-intensive care unit

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Outcome for stationary patients with high risk of variability

Time Frame: jan 2021 - dec 2025

hospitalization in semi-intensive care unit more than 2 days or transfer to intensive care unit

Outcome for high risk patients

Time Frame: jan 2021 - dec 2025

transfer to intensive care unit or hospital mortality

Outcome for low gravity patients, with a low organ's damage

Time Frame: jan 2021 - dec 2025

deterioration of the physiopathologic index

Outcome for semi-intensive patients

Time Frame: jan 2021 - dec 2025

transfer to intensive care unit or hospital mortality

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Mario Negri Institute for Pharmacological Research
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (34)

Loading locations...

Similar Trials